Approval · Notice of Compliance 38172 · 2026
VEVZUO: Notice of Compliance 38172
Issued August 28, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38172
- Date
- August 28, 2026
- Company
- Biocon Biologics Canada IncToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative – Change in Product Ownership
- Canadian reference product
- XGEVA
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VEVZUO | Not yet assigned | — |
Medicinal ingredients
- DENOSUMAB 120 MG per 1.7ML